John Tellew
21Patents
7h-index
22Co-inventors
69Inventor score
Filing activity: Dec 14, 2000 → Jul 15, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6852745B2 | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | Chemistry; Metallurgy | 42 | Expired |
| US8501758B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 31 | Active |
| US8242260B2 | Compounds and compositions as protein kinase inhibitors | Human Necessities | 9 | Active |
| US8563553B2 | Compounds and compositions as protein kinase inhibitors | Human Necessities | 9 | Active |
| US6638937B2 | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | Chemistry; Metallurgy | 8 | Expired |
| US9593100B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9593099B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9314464B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 7 | Active |
| US9850230B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 6 | Active |
| US9850229B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 5 | Active |
| US9580426B2 | Compounds that expand hematopoietic stem cells | Chemistry; Metallurgy | 4 | Active |
| US8927281B2 | Method for expanding hematopoietic stem cells | Chemistry; Metallurgy | 4 | Active |
| US6835741B2 | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | Chemistry; Metallurgy | 4 | Expired |
| US10005761B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 3 | Active |
| US10568884B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US10576080B2 | Compounds and compositions as protein kinase inhibitors | Chemistry; Metallurgy | 1 | Active |
| US7879862B2 | Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists | Human Necessities | 1 | Active |
| US7652035B2 | CRF receptor antagonists and methods relating thereto | Human Necessities | 1 | Active |
| USRE49556E1 | Compounds and compositions as protein kinase inhibitors | General | 0 | Active |
| US9181238B2 | N-(pyridin-2-yl)sulfonamides and compositions thereof as protein kinase inhibitors | Chemistry; Metallurgy | 0 | Active |
| US8859548B2 | Compounds and compositions as protein kinase inhibitors | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.